Archive

2010, Vol. 120, No. 3

March 01, 2010

previous issue next issue

Increasing the dose of inhaled corticosteroid when asthma deteriorates – does it prevent severe exacerbations?

Helen K. Reddel

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 64-67 / DOI: 10.20452/pamw.885

Angiotensin receptor blockers in patients with heart failure and a reduced left ventricular ejection fraction. Implications of the HEAAL trial

Bertram Pitt

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 68-70 / DOI: 10.20452/pamw.887

Prevalence of anticardiolipin antibodies in type 1 diabetes and autoimmune thyroiditis

Ayhan Abaci, Ece Bober, Ediz Yeşilkaya, Aysun Bideci, Peyami Cinaz, Atilla Buyukgebiz

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 71-75 / DOI: 10.20452/pamw.889

Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies

Marzena Olesińska, Hanna Chwalińska‑Sadowska, Ewa Więsik‑Szewczyk, Paweł Mielnik, Jakub Ząbek

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 76-81 / DOI: 10.20452/pamw.891

Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease

Marek Sanak, Hanna Plutecka, Wojciech Szczeklik, Wiesława Piwowarska, Paweł Rostoff, Andrzej Szczeklik

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 82-88 / DOI: 10.20452/pamw.893

The benefits and harms of screening for cancer with a focus on breast screening

John Brodersen, Karsten J. Jørgensen, Peter C. Gøtzsche

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 89-94 / DOI: 10.20452/pamw.895

Which patients with chronic heart failure should be referred for CRT‑D implantation? Practical implications of current clinical research

Wojciech Zareba, Karolina M. Zareba

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 95-102 / DOI: 10.20452/pamw.897

Antileukotriene drugs in the treatment of asthma

Lucyna Mastalerz, Jagoda Kumik

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 103-108 / DOI: 10.20452/pamw.899

Could glycated hemoglobin be used as a diagnostic tool in diabetes mellitus?

Józef Drzewoski, Agata Drozdowska

Pol Arch Intern Med. 2010, Vol. 120, No. 3: 109-114 / DOI: 10.20452/pamw.901

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200

Average times from:
submission to 1st decision, 2 days
submission to first reviews, 23 days
acceptance to online first publication, 7 days
acceptance to final publication, 91 days

Current manuscript acceptance rate: 28%

The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more